These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 34589112)
1. Identification of Signature Genes Associated With Invasiveness and the Construction of a Prognostic Model That Predicts the Overall Survival of Bladder Cancer. He Y; Wu Y; Liu Z; Li B; Jiang N; Xu P; Xu A Front Genet; 2021; 12():694777. PubMed ID: 34589112 [No Abstract] [Full Text] [Related]
2. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
3. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
4. Identification of a Nuclear Mitochondrial-Related Multi-Genes Signature to Predict the Prognosis of Bladder Cancer. Jiang X; Xia Y; Meng H; Liu Y; Cui J; Huang H; Yin G; Shi B Front Oncol; 2021; 11():746029. PubMed ID: 34692528 [TBL] [Abstract][Full Text] [Related]
5. Identification of an immune-related long non-coding RNA signature and nomogram as prognostic target for muscle-invasive bladder cancer. Song Y; Jin D; Chen J; Luo Z; Chen G; Yang Y; Liu X Aging (Albany NY); 2020 Jun; 12(12):12051-12073. PubMed ID: 32579540 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465 [TBL] [Abstract][Full Text] [Related]
7. Identifying a hypoxia related score to predict the prognosis of bladder cancer: a study with The Cancer Genome Atlas (TCGA) database. Zhang Z; Li Q; Li A; Wang F; Li Z; Meng Y; Zhang Q Transl Androl Urol; 2021 Dec; 10(12):4353-4364. PubMed ID: 35070817 [TBL] [Abstract][Full Text] [Related]
8. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer. Wu M; Li X; Zhang T; Liu Z; Zhao Y Front Oncol; 2019; 9():996. PubMed ID: 31612115 [No Abstract] [Full Text] [Related]
9. A TP53-based immune prognostic model for muscle-invasive bladder cancer. Li H; Lu H; Cui W; Huang Y; Jin X Aging (Albany NY); 2020 Dec; 13(2):1929-1946. PubMed ID: 33323544 [TBL] [Abstract][Full Text] [Related]
10. Dysregulation of the Immune Microenvironment Contributes to Malignant Progression and Has Prognostic Value in Bladder Cancer. Zheng Z; Mao S; Zhang W; Liu J; Li C; Wang R; Yao X Front Oncol; 2020; 10():542492. PubMed ID: 33392066 [TBL] [Abstract][Full Text] [Related]
11. A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies. Xu Y; Chen Y; Niu Z; Xing J; Yang Z; Yin X; Guo L; Zhang Q; Qiu H; Han Y Front Med (Lausanne); 2022; 9():841568. PubMed ID: 35492358 [TBL] [Abstract][Full Text] [Related]
12. Identification of Angiogenesis-Related Prognostic Biomarkers Associated With Immune Cell Infiltration in Breast Cancer. Tao D; Wang Y; Zhang X; Wang C; Yang D; Chen J; Long Y; Jiang Y; Zhou X; Zhang N Front Cell Dev Biol; 2022; 10():853324. PubMed ID: 35602610 [No Abstract] [Full Text] [Related]
13. Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer. Zhang F; Wang X; Bai Y; Hu H; Yang Y; Wang J; Tang Y; Ma H; Feng D; Li D; Han P Front Genet; 2021; 12():670384. PubMed ID: 34122523 [TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y Front Oncol; 2021; 11():769727. PubMed ID: 34926275 [TBL] [Abstract][Full Text] [Related]
15. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy. Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646 [No Abstract] [Full Text] [Related]
16. Analysis of genomics and immune infiltration patterns of epithelial-mesenchymal transition related to metastatic breast cancer to bone. Liu S; Song A; Wu Y; Yao S; Wang M; Niu T; Gao C; Li Z; Zhou X; Huo Z; Yang B; Liu Y; Wang Y Transl Oncol; 2021 Feb; 14(2):100993. PubMed ID: 33333372 [TBL] [Abstract][Full Text] [Related]
17. Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer. Shen C; Xu T; Sun Y; Wang L; Liang Z; Niu H; Jiao W; Wang Y Dis Markers; 2020; 2020():8866730. PubMed ID: 33456631 [TBL] [Abstract][Full Text] [Related]
18. Construction and evaluation of a novel prognostic risk model of aging-related genes in bladder cancer. Wang D; Ning H; Wu H; Song Y; Chu Y; Liu F; Zhao Z; Wu F; Lyu J Curr Urol; 2023 Dec; 17(4):236-245. PubMed ID: 37994343 [TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module. Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152 [TBL] [Abstract][Full Text] [Related]
20. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer. Yang KS; Xu CQ; Lv J Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]